A compound hidden in broccoli could help fight a devastating genetic disease

Researchers have found that sulforaphane, a compound in broccoli, may help treat Friedreich ataxia by increasing levels of the protein frataxin. This discovery offers hope for a more accessible treatment for this rare, progressive genetic disease.
Why it matters
Finding affordable, natural compounds to treat rare genetic diseases could significantly improve the quality of life for patients with limited therapeutic options.
A natural substance found in broccoli could offer an unexpected new approach to treating a devastating genetic disease that progressively damages the nervous system. Researchers at Swinburne University have identified promising effects from the compound, raising hopes for a more affordable and accessible treatment for patients with few available options.
The disease, known as Friedreich ataxia, causes nerve cells in the brain and spinal cord to gradually deteriorate. As the damage progresses, patients lose their ability to coordinate movements, walk, and speak. The condition can also shorten life expectancy, and there is currently no cure. Approximately 200 Australians are living with the disease.
In a new study, scientists found that sulforaphane, a naturally occurring compound in broccoli, can increase levels of frataxin, a protein that is present in insufficient amounts in people with Friedreich ataxia. The researchers also found that the compound can help protect vulnerable nerve cells from damage.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in